Galera Announces Presentation of Phase 3 ROMAN Long-term Follow-up Data at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting
Tumor outcomes and overall survival maintained in patients with HNC at one-year Cisplatin-related chronic kidney…